SBT-300
Singh Biotechnology
SBT-300
Pipeline
SBT Pipeline
Development Stage
Therapeutic
Target(s)
Route of Administration
Indications
Research
Preclinical
IND
SBT-300
KRAS & STAT3
Topical
Non-Melonoma Skin Cancers (BCCA & SBCA), Actinic Keratosis